Form 8-K - Current report:
SEC Accession No. 0001493152-18-008568
Filing Date
2018-06-13
Accepted
2018-06-13 06:06:30
Documents
5
Period of Report
2018-06-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 27872
2 ex99-1.htm EX-99.1 22404
3 ex99-1_001.jpg GRAPHIC 15760
4 ex99-1_002.jpg GRAPHIC 32464
5 ex99-1_003.jpg GRAPHIC 4821
  Complete submission text file 0001493152-18-008568.txt   125073
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51353 | Film No.: 18895833
SIC: 7389 Services-Business Services, NEC